Study of DF9001 in Patients With Advanced Solid Tumors

Clinical trial NCT05597839 · COMPLETED

Trial details

NCT number: NCT05597839
Sponsor: Dragonfly Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2022-11-15
Primary completion: 2025-08-15
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.